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Introduction
Prediction by Nonparametric Posterior Estimation in Virtual Screening
Virtual Screening (VS)
- Rank molecules so that most likely 
actives assayed first. 
Binary Kernel Discrimination (BKD)
- Score   Likelihood Ratio (LR) of active 
and inactive.
- Estimated by Parzen Windows.
Objectives
- Compute LR via direct estimate of 
posterior probability.
- Use non-parametric generalisation of 
logistic regression (Kernel Logistic 
Regression.
- Control complexity via Lq penalty 
function.
Fig. 2: Virtual Screening
>>MDL Drug Data Report (MDDR) database
>>1,024-D fingerprints representing 102,514 
known drugs and biologically relevant 
molecules.
>>11 activity classes selected - reflect typical 
industrial drug discovery projects.
>> Our BKD outperforms proposed method 
using J/T.
>> KLR & SLR only predict the probability of 
being Active.
>> Sparsity can be controllable but 
decreases in heterogeneous samples.
>>  Sparseness desirable for high-through-
put VS applications when computation of 
time is important.
Table 1: Self-Similarity, percent actives 
retrieved in top 5% of samples and its retained 
features
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Hamming Distance (HD): Conventional
Jaccard/Tanimoto Distance (J/T): [1]
Fig. 3: Fingerprint
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1 Renin Inhibitors 0.337 0.105 99.10 99.19 98.51 98.29
(226) 51.68 11.95
2 Angiotensin II AT1 Antagonists  0.269 0.100 97.43 99.01 98.47 98.37
(190) 65.26 24.84
3 HIV Protease Inhibitors 0.226 0.101 94.70 93.69 92.80 93.60
(150) 90.00 77.33
4 Thrombin Inhibitors 0.212 0.098 94.02 93.38 94.04 92.24
(162) 76.79 74.94
5 Substance P Antagonists 0.179 0.082 93.70 93.52 90.99 91.90
(250) 94.16 85.28
6 5HT3 Antagonists 0.175 0.090 93.88 93.29 90.64 90.87
(150) 96.00 82.27
7 D2 Antagonists 0.173 0.089 77.97 76.85 73.30 68.73
(80) 99.70 71.50
8 5HT1A Agonists 0.166 0.086 88.28 88.06 85.27 83.84
(166) 96.75 75.54
9 5HTReuptake Inhibitors 0.153 0.092 73.62 73.19 69.16 67.00
(72) 98.61 85.28
10 Protein Kinase C Inhibitors 0.141 0.103 81.23 79.66 75.68 71.74
(92) 98.04 74.57
11 Cyclo-oxygenase Inhibitors 0.130 0.073 76.26 76.78 69.83 69.27
(128) 99.69 92.81
Idx Activity Class Self-Similarity BKD KLR SLR1 SLR0.5
Logistic Model: 
Linear Model: “Kernel trick”
Minimise the Likelihood Function:
Kernel Logistic Regression (KLR)
Solved by using iteratively re-weighted 
least square (IRLS) algorithm.
Sparse Logistic Regression (SLR)
where,
Solved by using EM-like algorithm 
– Same computational complexity as 
IRLS. 
– Solve non-convex problem.
01 q < ≤
Kernel Logistic Regression
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Fig. 1: Enrichment Plot
Fig. 4: Accuracy       Homogeneity ∝
Fig. 5: Sparsity         Homogeneity ∝
Kernel Function
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